Efficient Fungicide Delivery
Most antifungal therapies struggle to enter fungal cells efficiently and lack the specificity needed to minimize collateral damage to host cells. The result is poor potency, high systemic exposure, widespread toxicity, and growing resistance. Dose escalation remains the default strategy—especially in the lungs, and specifically in invasive fungal infections like pulmonary aspergillosis, where dense mucus and fragile tissue make precision delivery even harder. Phoreus created water soluble PNP which allows therapeutic payload to reach sites of pathogen infection without overwhelming the rest of the body. Initial applications focus on difficult to treat pulmonary infections like Aspergillus and Candida auris.
Advantages of PNPs in Fungicide Delivery
Phoreus’ PNPs are addressing the major challenges of fungicide delivery, aiming for a safer, more efficient, and patient-friendly solution. Here’s how:
- Improved Bioavailability: PNPs are designed to enhance the amount of fungicide that reaches its target, potentially supporting better therapeutic outcomes with reduced active ingredient requirements.
- Reduced Cost of Goods: By enhancing bioavailability, PNPs could lower the amount of drug needed, significantly cutting production costs.
- Fewer Side Effects: Unlike traditional systems that rely on permeability enhancers (which can cause gastrointestinal issues), PNPs are designed to support absorption without these additives, potentially enhancing patient comfort.
Phoreus PNPs are not just improving fungicide delivery, they’re paving the way for more accessible, patient-centric therapies that could transform care for this difficult-to-treat class of diseases.
Technology Description
Corralling Amphipathic Peptide Colloids (CAPC®) represent a new class of nanocarriers designed from a naturally occurring peptide sequence. Similar to BAPC®, CAPC® is being explored as a delivery system for insoluble active ingredients, including certain antibiotics, fungicides, and cancer therapies. Researchers are investigating its potential to improve cellular uptake of small molecules with poor solubility and low permeability, potentially broadening the range of viable drug candidates.
Preliminary studies suggest that CAPC® may support efficient encapsulation and intracellular delivery of hydrophobic active ingredients. Its surface binding properties could allow for attachment of targeting moieties, helping direct active ingredients to specific cells.
As research continues, CAPC® holds promise as a tool for bridging in vitro studies with in vivo applications, providing a platform for further exploration of its potential uses.